Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zituvio™ (sitagliptin) – New drug approval
October 20, 2023 - Zydus Lifesciences announced the FDA approval of Zituvio (sitagliptin), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
